Jean-Philippe Camdessanché

31PUBLICATIONS
141CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Peripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Sep 30, 2026
Rituximab With or Without Chemotherapy for Anti-MAG Neuropathy: A Retrospective Multicenter Real-World Study.

|Sep 26, 2026
Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack.

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|May 20, 2026
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

|May 15, 2026
Clinical, Electrophysiological, and Neuropathological Features of Peripheral Neuropathies in People With T-Cell Lymphoproliferative Disorder.

|May 05, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Pageof 6

Frequent Collaborators

10 joint publications

Guillaume Mathey

9 joint publications

Jonathan Ciron

9 joint publications

Christine Lebrun-Frenay

7 joint publications

Magy Laurent